An editor has nominated this article for deletion. You are welcome to participate in the deletion discussion, which will decide whether or not to retain it. |
This article needs additional citations for verification. (July 2022) |
VNN is a venture capital and private equity company belonging to Votorantim Group.[1] The company is based in São Paulo, Brazil and currently has investments in eight companies: Amyris Biotech, Anfreixo, Base Metals, Moksha8, Nitro Química, Quadrem and SAM.
| Company type | Private |
|---|---|
| Industry | Private Equity & Venture Capital |
| Founded | (1996) |
| Headquarters | São Paulo, Brazil |
Key people | Paulo Henrique de Oliveira Santos, (CEO) |
| Products | Investment company |
Number of employees | 25,700[citation needed] |
| Parent | Votorantim Group |
| Website | www.vventures.com.br |
The company invests in companies in early stage of development with high growth potential and also in more mature businesses, where value creation stems from the renewal of the operating model or business.[2][3]
VNN has experience in business structuring, mergers and acquisitions, practice in strategic management, financial, operational and human resources and expertise of business sectors such as life sciences, technology services and mineral exploration.[citation needed]
References
edit- ^ "Votorantim Novos Negocios - VNN is a venture capital and private equity firm. | Startup Ranking". StartupRanking. Retrieved 2022-06-07.
- ^ "Votorantim Novos Negocios Ltda. Company Profile - Brazil | Contacts & Key Executives | EMIS". www.emis.com. Retrieved 2022-06-07.
- ^ "Votorantim busca crescer em novos negócios e em países de moeda forte". Valor Econômico (in Brazilian Portuguese). 6 April 2022. Retrieved 2022-06-07.
  | This article about a private equity or venture capital firm is a stub. You can help Wikipedia by expanding it. |